TrumpRx Platform Launches to Offer Prescription Drug Discounts

The TrumpRx initiative introduces a federal website designed to help consumers find lower prices on prescription medications by linking them to manufacturer discounts and printable coupons. The platform is part of a broader government strategy to address prescription drug costs in the United States.

TrumpRx does not directly sell medications. Instead, it provides links to pharmaceutical company websites or offers coupons that can be used at participating pharmacies for discounted prices. The website is intended to serve individuals who are uninsured, pay cash for prescriptions, or have high-deductible health plans.

At its launch, the platform featured approximately 40 to 43 medications from several major pharmaceutical companies, including Pfizer, Eli Lilly, Novo Nordisk, AstraZeneca, and EMD Serono. The discounts available through TrumpRx vary depending on the drug, with some medications showing substantial price reductions compared to typical retail prices.

What the numbers show

• TrumpRx launched on February 5, 2026
• About 40–43 medications were included at launch
• Wegovy listed at $199/month, down from about $1,349
• Cetrotide discounted by approximately 93%
• Pfizer offered discounts averaging 50% off list price, up to 85% for some drugs

The pricing approach used by TrumpRx is based on a most-favored-nation model, which aims to align U.S. medication prices with the lowest prices paid in other developed countries. According to published information, Pfizer agreed to provide its drugs to state Medicaid programs at these most-favored-nation prices and to offer direct-to-consumer discounts through the platform.

While TrumpRx is designed to benefit those without insurance or with high out-of-pocket costs, most insured Americans may still find lower prices through their existing insurance coverage. For many insured patients, purchases made through TrumpRx may not count toward their insurance deductibles or out-of-pocket maximums, which could result in higher overall costs compared to using their insurance plans.

The development and launch of the TrumpRx website involved contributions from Joe Gebbia, co-founder of Airbnb, who assisted with the platform's design. Dr. Mehmet Oz, serving as CMS Administrator, participated in the official launch event for the website.

The TrumpRx platform was introduced as part of a broader set of policy measures by the Trump administration to address drug pricing ahead of the 2026 midterm elections. These measures included the adoption of the most-favored-nation pricing model and negotiations related to pharmaceutical tariffs.

Some analysts and experts have stated that the transparency and actual consumer benefits of TrumpRx may be limited, as many medications could still be less expensive through insurance or other existing discount programs. The platform's impact on overall drug affordability remains under review by various stakeholders.

* This article is based on publicly available information at the time of writing.